Analysis of the risk factors for allograft vasculopathy in asymptomatic patients after cardiac transplantation

OBJECTIVE: To study the influence of immune and nonimmune risk factors on the development of allograft vasculopathy after cardiac transplantation. METHODS: We studied 39 patients with a mean age of 46±12 years. The following variables were analyzed: weight (kg), body mass index (kg/m²), donor's...

Full description

Bibliographic Details
Main Authors: Fernando Bacal, Viviane Cordeiro Veiga, Alfredo Inácio Fiorelli, Giovanni Bellotti, Edimar Alcides Bocchi, Noedir Antonio Groppo Stolf, José Antonio Franchini Ramires
Format: Article
Language:English
Published: Sociedade Brasileira de Cardiologia (SBC) 2000-11-01
Series:Arquivos Brasileiros de Cardiologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2000001100006
_version_ 1828365745175658496
author Fernando Bacal
Viviane Cordeiro Veiga
Alfredo Inácio Fiorelli
Giovanni Bellotti
Edimar Alcides Bocchi
Noedir Antonio Groppo Stolf
José Antonio Franchini Ramires
author_facet Fernando Bacal
Viviane Cordeiro Veiga
Alfredo Inácio Fiorelli
Giovanni Bellotti
Edimar Alcides Bocchi
Noedir Antonio Groppo Stolf
José Antonio Franchini Ramires
author_sort Fernando Bacal
collection DOAJ
description OBJECTIVE: To study the influence of immune and nonimmune risk factors on the development of allograft vasculopathy after cardiac transplantation. METHODS: We studied 39 patients with a mean age of 46±12 years. The following variables were analyzed: weight (kg), body mass index (kg/m²), donor's age and sex, rejection episodes in the first and second years after transplantation, systolic and diastolic blood pressures (mmHg), total cholesterol and fractions (mg/dL), triglycerides (mg/dL), diabetes, and cytomegalovirus infection. The presence of allograft vasculopathy was established through coronary angiography. RESULTS: Allograft vasculopathy was observed in 15 (38%) patients. No statistically significant difference was observed between the two groups in regard to hypertension, cytomegalovirus infection, diabetes, donor's sex and age, rejection episodes in the first and second years after transplantation, and cholesterol levels. We observed a tendency toward higher levels of triglycerides in the group with disease. Univariate and multivariate analyses showed statistically significant differences between the two groups when we analyzed the body mass index (24.53±4.3 versus 28.11±4.6; p=0.019). CONCLUSION: Body mass index was an important marker of allograft vasculopathy in the population studied.
first_indexed 2024-04-14T05:36:08Z
format Article
id doaj.art-efcca3a5393b405a8a2be4adb52fca13
institution Directory Open Access Journal
issn 0066-782X
1678-4170
language English
last_indexed 2024-04-14T05:36:08Z
publishDate 2000-11-01
publisher Sociedade Brasileira de Cardiologia (SBC)
record_format Article
series Arquivos Brasileiros de Cardiologia
spelling doaj.art-efcca3a5393b405a8a2be4adb52fca132022-12-22T02:09:39ZengSociedade Brasileira de Cardiologia (SBC)Arquivos Brasileiros de Cardiologia0066-782X1678-41702000-11-0175542142810.1590/S0066-782X2000001100006Analysis of the risk factors for allograft vasculopathy in asymptomatic patients after cardiac transplantationFernando BacalViviane Cordeiro VeigaAlfredo Inácio FiorelliGiovanni BellottiEdimar Alcides BocchiNoedir Antonio Groppo StolfJosé Antonio Franchini RamiresOBJECTIVE: To study the influence of immune and nonimmune risk factors on the development of allograft vasculopathy after cardiac transplantation. METHODS: We studied 39 patients with a mean age of 46±12 years. The following variables were analyzed: weight (kg), body mass index (kg/m²), donor's age and sex, rejection episodes in the first and second years after transplantation, systolic and diastolic blood pressures (mmHg), total cholesterol and fractions (mg/dL), triglycerides (mg/dL), diabetes, and cytomegalovirus infection. The presence of allograft vasculopathy was established through coronary angiography. RESULTS: Allograft vasculopathy was observed in 15 (38%) patients. No statistically significant difference was observed between the two groups in regard to hypertension, cytomegalovirus infection, diabetes, donor's sex and age, rejection episodes in the first and second years after transplantation, and cholesterol levels. We observed a tendency toward higher levels of triglycerides in the group with disease. Univariate and multivariate analyses showed statistically significant differences between the two groups when we analyzed the body mass index (24.53±4.3 versus 28.11±4.6; p=0.019). CONCLUSION: Body mass index was an important marker of allograft vasculopathy in the population studied.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2000001100006cardiac transplantationallograft vasculopathyrisk factorsbody mass index
spellingShingle Fernando Bacal
Viviane Cordeiro Veiga
Alfredo Inácio Fiorelli
Giovanni Bellotti
Edimar Alcides Bocchi
Noedir Antonio Groppo Stolf
José Antonio Franchini Ramires
Analysis of the risk factors for allograft vasculopathy in asymptomatic patients after cardiac transplantation
Arquivos Brasileiros de Cardiologia
cardiac transplantation
allograft vasculopathy
risk factors
body mass index
title Analysis of the risk factors for allograft vasculopathy in asymptomatic patients after cardiac transplantation
title_full Analysis of the risk factors for allograft vasculopathy in asymptomatic patients after cardiac transplantation
title_fullStr Analysis of the risk factors for allograft vasculopathy in asymptomatic patients after cardiac transplantation
title_full_unstemmed Analysis of the risk factors for allograft vasculopathy in asymptomatic patients after cardiac transplantation
title_short Analysis of the risk factors for allograft vasculopathy in asymptomatic patients after cardiac transplantation
title_sort analysis of the risk factors for allograft vasculopathy in asymptomatic patients after cardiac transplantation
topic cardiac transplantation
allograft vasculopathy
risk factors
body mass index
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2000001100006
work_keys_str_mv AT fernandobacal analysisoftheriskfactorsforallograftvasculopathyinasymptomaticpatientsaftercardiactransplantation
AT vivianecordeiroveiga analysisoftheriskfactorsforallograftvasculopathyinasymptomaticpatientsaftercardiactransplantation
AT alfredoinaciofiorelli analysisoftheriskfactorsforallograftvasculopathyinasymptomaticpatientsaftercardiactransplantation
AT giovannibellotti analysisoftheriskfactorsforallograftvasculopathyinasymptomaticpatientsaftercardiactransplantation
AT edimaralcidesbocchi analysisoftheriskfactorsforallograftvasculopathyinasymptomaticpatientsaftercardiactransplantation
AT noedirantoniogroppostolf analysisoftheriskfactorsforallograftvasculopathyinasymptomaticpatientsaftercardiactransplantation
AT joseantoniofranchiniramires analysisoftheriskfactorsforallograftvasculopathyinasymptomaticpatientsaftercardiactransplantation